medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2011, Número 2

<< Anterior Siguiente >>

Arch Neurocien 2011; 16 (2)


Herramientas auxiliares de diagnóstico en neurocisticercosis

Cárdenas HGA

Idioma: Español
Referencias bibliográficas: 92
Paginas: 90-97
Archivo PDF: 845.84 Kb.


RESUMEN

A pesar del avance en el estudio de las enfermedades parasitarias para la comprensión de su ciclo biológico; la farmacoterapia y los métodos auxiliares de diagnóstico la neurocisticercosis (NCC); sigue siendo un gran problema de salud pública en México y otras regiones de Latinoamérica. Dado que las manifestaciones clínicas propias de esta enfermedad pueden ser pleomórficas (cefalea, epilepsia, hipertensión intracraneal, déficit motores, alteraciones neuropsiquiátricas o movimientos anormales) es mandatorio contar con métodos auxiliares de diagnóstico, donde la neuroimagen constituye un importante pilar en el diagnóstico de esta patología. Las imágenes de resonancia magnética (RM) ponderadas en T1 y T2 constituyen hoy en día la herramienta más sensible y específica para el diagnóstico de NCC; a pesar de ello, en circunstancias particulares no es posible definir los parásitos vesiculares entre otras lesiones quísticas, por lo que las secuencias de RM como FLAIR (Fluid Attenuation Inversion Recovery), FIESTA (Fast imaging Employing STeady-state Acquisition) y espectroscopia han demostrado su utilidad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Del Brutto OH, Rajshekhar V, White Jr AC, Tsang VCW, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001; 57: 177-83.

  2. Botero D, Tanowitz HB, Weiss LM, Wittner M. Taeniasis and cysticercosis. Infect Dis Clin North Am 1993; 7: 683-97.

  3. Richards F, Schantz PM. Laboratory diagnosis of cisticercosis. Clin Lab Med 1991;11:1011-28.

  4. Monteiro L, Almeida-Pinto JA, Aampaio –Silva M. Active neurocysticercosis, parenchymal and extraparenchymal: a study of 38 patients. J Neurol 1993;241:15-21.

  5. McCormick GF, Zee CS, Heiden J. cysticercosis cerebri. Review of 127 cases. Arch Neurol 1982;39:534-9.

  6. Loo L, Braude A. Cerebral cysticercosis in San Diego. A report of 23 cases and a review of literature. Medicine 1982;61: 341-9.

  7. Del Brutto OH, Sotelo J, Roman GC. Neurocysticercosis: a clinical handbook Lisse: Swets & Zeitlinger, 1998.

  8. Barry M, Kaldjian LC. Neurocysticercosis. Sem Neurol 1993, 13:131-45.

  9. Cárdenas G, Jung H, Rios C, Fleury A, Soto-Hernandez JL. Severe cysticercal meningitis: clinical and imaging characteristics. Am J Trop Med 2010;82:121-5.

  10. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive form. Arch Intern Med 1985;145 :442-5.

  11. Torabi AM, Quinceno M, Medelsohn DB, Powell CM. Multilevel intramedullary spinal neurocysticercosis with eosinophilic meningitis. Arch Neurol 2004;61:770-2.

  12. Del Brutto OH, Sotelo J. Neurocysticercosis: An update. Rev Infect Dis 1988;10:1075-87.

  13. Gang-zhi W, Cun-jiang L, Jia-mei M, Ming-Chen D. Cysticercosis of the central nervous system. A clinical study of 1400 cases. Chin Med J 1988;101:493-500.

  14. Monteiro L, Almeida-Pinto J, Leite I, Xavier J, Correira M. Cerebral cysticercus arteritis: five angiographic cases. Cerebrovasc Dis 1994;4:125-7.

  15. Finsterer J, Li M, Rasmkogeler K, Auer H. Chronic long-standing headache due to neurocysticercosis. Headache 2006;46(3):523-4.

  16. Livramento JA. A cerebrospinal fluid syndrome in neurocysticercosis. Arq Neuropsiquiatr 1987;45:261-75.

  17. Barcelos IS, Mineo JR, de Oliveira Silva DA, Ferreira MS, de Moura LP, Biondi GF, et al. Detection of IgG in cerebrospinal fluid for diagnosis of neurocysticercosis: evaluation of saline and SDS extracts from Taenia solium and Taenia crassiceps metacestodes by Elisa and immunoblot assay. Trop Med Int Health 2001; 6: 219-26.

  18. Ramos-Kuri M, Montoya RM, Padilla A, Govenzensky T, Diaz ML, Sciutto E, Sotelo J, Larralde C. Immunodiagnosis of neurocysticercosis. Disappointing performance of serology (Enzyme-linked immunosorbent assay) in an unbiased sample of neurological patients. Arch Neurol 1992;49:633-6.

  19. Deckers N, Domy P. Immunodiagnosis of Taenia solium taeniosis/ cysticercosis. Trends Parasitol 2010;26:137-44.

  20. Ordoñez G, Medina MT, Sotelo J. Immunoblot analysis of serum and CSF from patients with various forms of neurocysticercosis. Neurol Infect Epidemiol 1996;1:57-61.

  21. Fleury A, Hernández M, Fragoso G, Parkhouse RME, Harrison LJS, Sciutto E. Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis. Trans Soc Trop Med Hyg 2003;97:542-6.

  22. Dumas M, Grunitzky K, Belo M, Dabis F, Daniau M, Bouteille B, Kassankogno Y, Catanzano G, Alexandre MP. Cysticercose et neurocysticercose: enquete épidémiologique dans le nord du Togo. Bull Soc Pathol Exot 1996;89:45-7.

  23. Mafojane NA. The neurocysticercosis project in Atteridgeville- Mamelodi townships. South Afr Med J 1994;84:208-11.

  24. Preux PM, Melaku Z, Druet-Cabanac M, Avode G, Grunitzky EK, Bouteille B, et al. Cysticercosis and neurocysticercosis in Africa: current status. Neurol Infect Epidemiol 1996;1:63-8.

  25. Fleury A, Hernandez M, Avila M, Cardenas G, Bobes RJ, Huerta M, et al. Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis. J Neurol Neurosurg Psychiatry 2007;78:970-4.

  26. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectro transfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989; 159: 50-9.

  27. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991; 164: 1007-9.

  28. Chang KH, Kim WS, Cho SY, Han MC, Kim CW. Comparative evaluation of brain CT and Elisa in the diagnosis of neurocysticercosis. AJNR Am J Neuroradiol 1988; 9: 125-30.

  29. Ito A, Plancarte A, Ma L, Kong Y, Flisser A, Cho SY, et al. Novel antigens for neurocysticercosis: simple method for preparation and evaluation for serodiagnosis. Am J Trop Med Hyg 1998; 59: 291-4.

  30. García HH, González AE, Evans CAW, Gilman RH. For the Cysticercosis Working Group in Peru. Taenia solium cysticercosis. Lancet 2003; 362: 547-56.

  31. Garcia HH, Gonzalez AE, Tsang VCW, Gilman RH. For the Cysticercosis Working Group in Peru. Neurocysticercosis: some of the essentials. Practical Neurology 2006; 6: 288-97.

  32. Almeida CR, Ojopi EP, Nunes CM, Machado LR, Takayanagui OM, Livramento JA, Abraham R, Gattaz WF, Vaz AJ, Dias-Neto E. Taenia solium DNA is present in the cerebrospinal fluid of neurocysticercosis patients and can be used for diagnosis. Eur Arch Psychiatry Clin Neurosci 2006;256:307-10.

  33. Meri T, Jorikanta TS, Granat S, Collander F, Valtoren M, Meri S. Diagnosis of atypical neurocysticercosis by polymerase chain reaction analysis : case report. Clin Infect Dis 1999; 28:1331-2.

  34. Yamasaki H, Nakao M, Sako Y, Nakaya K, Ito A Molecular identification of Taenia solium cysticercus genotype in the histopathological specimens. Southeast Asian J Trop Med Public Health 2005; 36:131-4.

  35. Year H, Dupont D, Houze S, M’rad MB, Pilleux F, Sulahjan A, Gatey C, Andrieu FG, Dupoy-Carnet J. Confirmation and follow-up of neurocysticercosis by real-time PCR in cerebrospinal fluid of patients living in France. J Clin Microbiol 2011;Oct 5 [Epub ahead of print].

  36. Carbajal JR, Palacios E, Azar-kia B, Churchill R. Radiology of cysticercosis of the central nervous system including computed tomography. Radiology 1977;125:127-31.

  37. Bentson JR, Wilson GH, Helmer E, Winter J. Computed tomography in intracranial cysticercosis. J Comput Assist Tomogr 1977;1:464-71.

  38. Dhamija RM, Venkatarama S, Snachetee PC, Roy AK, Bathia HC. Computed tomographic spectrum of neurocysticercosis. J Assoc Physicians India 1990;38:566-8.

  39. Rodriguez-Carbajal J, Boleaga-Durán B, Dorfsman J. The role of computed tomography in the diagnosis of neurocysticercosis. Child´s Nerv Syst 1987;3:199-202.

  40. Del Brutto OH. Single parenchymal brain cysticercosis in the acute encephalitic phase: definition of a distint form of neurocysticercosis with a bening prognosis. J Neurol Neurosurg Psychiatry 1995;58:247-9.

  41. Rodriguez Carbajal J, Palacios E, Zee CS. Neuroradiology of cisticercosis of the central nervous system. In: E. Palacios, J. Rodriguez Carbajal, JM Taveras. Cysticercosis of the nervous system 1983 (pp.101-143) Sprinfield, III: Charles C. Thomas publisher.

  42. Mazer S, Antoniuk A, Ditzel LFS, Araujo JC. The computed tomographic spectrum of cerebral cysticercosis. Comput Radiol 1983;7:373-8.

  43. Minguetti G, Ferreira MVC. Computed tomography in Neurocysticercosis. J Neurol Neurosurg Psychiatry 1983;46:936-42.

  44. Rodriguez Carbajal J, Arredondo Estrada H, Vázquez Sánchez H. La neuroradiología de la neurocisticercosis humana. Rev Mex Radiol 1990;44:157-64.

  45. Escobar A, Nieto D. Parasitic diseases. In: J. Minckler J (Ed). Pathology of the nervous system, 1972; (3):2503-21. New York: McGraw-Hill Book Company.

  46. Del Brutto OH. Diagnosis and management of cysticercosis. J Trop Geogr Neurol 1992;2:1-9.

  47. Berman JD, Beaver PC, Cheever AW, Quindlen EA. Cysticercus of 60 milliliter volume in human brain. Am J Trop Med Hyg 1981;30:616-9.

  48. Muñoz C, Rodriguez-Carbajal J, Santoyo A, Zenteno MA. Lesiones del ángulo pontocerebeloso y su demostración topográfica y comparación con los estudios radiológicos. Neurología-Neurocirugía-Psiquiatria (Méx) 1984; 25: 13-22.

  49. Del Brutto OH, Sotelo J. Albedazole therapy for subarachnoid and ventricular cysticercosis: case report. J Neurosurg 1990;72:816-7.

  50. Facure NO, Guerreiro CAM, Facure JJ, Quagliato EMAB. Cisto cerebral gigante na neurocisticercose. Arq Bras Neurocir 1984;3:233-7.

  51. Rodacki MA, Detoni XA, Teixeira WR, Boer VH, Oliveira GG. CT features of cellulosae and racemosus neurocysticercosis. J comput Assist Tomogr 1989;13: 1013-6.

  52. Madrazo I, García-Rentería JA, Sandoval MA, Soto R. Intraventricular cysticercosis. Neurosurg 1983;12:148-52.

  53. Madrazo I, Rentería JAG, Paredes G, Olhagaray B. Diagnosis of intraventricular and cisticercal cysticercosis by computerized tomography with positive intraventricular contrast medium. J Neurosurg 1981;55:947-51.

  54. Del Bruttto OH, Guevara J, Sotelo J. Intrasellar cysticercosis. J Neurosurg 1988;69:58-60.

  55. Hernández-González LA, Arredondo-Mendoza E, Prado-Castro JA. Neurocisticercosis raquimedular en Guatemala: descripción del signo de «lesión quistica flotante». Rev Mex Radiol 1990;44:165-9.

  56. Castillo M, Quencer RM, Post MJD. MR imaging of intramedullary spinal cisticercosis. AJNR 1988;9:393-5.

  57. Isidro-Llorens A, Dacha F, Vidal J, Sarrias M. Spinal cysticercosis: case report and review. Paraplegia 1993;31:128-30.

  58. Martinez HR, Rangel-Guerra R, Elizondo G, González J, Todd LE, Ancer J, Prakash SS. MR imaging in neurocysticercosis: a study of 56 cases. AJNR 1989;10:1011-9.

  59. Do amaral LL, Ferreira RM. Da Rocha AJ, Ferreira NP. Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms. Top Magn Reson Imaging 2005;16:127-44.

  60. Barkovich AJ, Citrin CM, Klara P, Wippold FJ, Kattah J. Magnetic resonance imaging of cysticercosis. West J Med 1986; 145:687-90.

  61. Ramos OM, Stiebel-Chin G, Altman N, Duchowny M. Diagnosis neurocysticercosis by magnetic resonance imaging. Pediatr Infect Dis 1986;5:470-3.

  62. Tellez-Zenteno JF, Negrete-Pulido O, Cantú C, Márquez C, Veja-Boada F, García Ramos G. Neurología 2003; 18: 272-5.

  63. Teitelbaum GP, Otto RJ, Lin M, Watanabe AT, Stull MA, Manz HJ, Bradley WG. MR imaging of neurocysticercosis. AJNR 1989;153: 857-66.

  64. Couldwell WT, Zee CS, Apuzzo MLJ. Definition of the role of contemporary surgical management in cisternal and parenchymatous cysticercosis cerebri. Neurosurg 1991;28:231-7.

  65. Meneses MS, Arruda WO, Ramina R. Third ventricular cysticercal cyst mimicking a colloid cyst: case report. Neurosurgery 1996; 39:623.

  66. Rangel-Guerra R, Martínez HR. Neurocysticercosis. Arch Neurol 1988;45:492.

  67. Bandres JC, White AJ, Samo T, Murphy EC, Harris RL. Extraparenchymal neurocysticercosis: report of five cases and review management. Clin Infect Dis 1992;15:799-811.

  68. Malzacher VD. Bogumil-Scott E, Neu IS. Intraspinale manifestation der zystizerkose: cysticercus racemosus. Nervenartz 1994;65:563-7.

  69. Paterakis KN, Kapsalaki E, Hadjjgeorgiou GM, Barbanis S, Fezoulidis I, Kourtopoulos H. Primary spinal intradural extramedullary cysticercosis. Surg Neurol 2007;68:309-11.

  70. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003;4:469:80.

  71. Bergui M, Zhong J, Bradac GB, Sales S. Diffusion-Weighted images of intracranial cyst-like lesion. Neuroradiology 2001;43:824-9.

  72. Braga FT, da Rocha AJ, Hernandez-Filho G, Arikawa RK, Ribeiro IM, Fonseca RB. Relationship between the concentration of supplemental oxygen and signal intensity of CSF depicted by fluid-attenuated inversión recovery imaging. AJNR Am J Neuroradiol 2003;24:1863-8.

  73. Braga F, Rocha AJ, Gomes HR, Filho GH, Silva CJ, Fonseca RB. Noninvasive MR cisternography with fluid-attenuated inversion recovery and 100% supplemental O(2) in the evaluation of neurocysticercosis. AJNR 2004;25:295-7.

  74. Govindappa SS, Narayanan JP, Krishnamoorthy VM, Shastry CH, Balasubramaniam A, Krishna SS. Improved detection of intraventricular cysticercal cysts with the use of three-dimensional constructive interference in steady state MR sequences. AJNR 2000;21:679-84.

  75. Mayes PA. Glycolysis and the oxidation of pyruvate. In: Murray RK, Granner DK, Mayes PA, Rodwell VW (eds) Harper´s biochemistry. Prentice Hall pp. 176-184.

  76. Kohli A, Gupta RK, Poptani H, et al. In vivo proton magnetic resonance spectroscopy in a case of intracranial hydatid cyst. Neurology 1995;45:562-4.

  77. Jayakumar PN, Srikanth SG, Chandrashekar HS, Kovoor JM, Shankar SK, Anandh B. Piruvate an in vivo marker of cestodal infestation of the human brain on proton MR spectroscopy. J Magn Reson Imaging 2003;18:675-80.

  78. Jayakumar PN, Chandrashekar HS, Shrikanth SG, Guruprasad AS, Indira Devi, Shankar SK. MRI and in vivo proton MR spectroscopy in a racemose cysticercal cyst of the brain. Neuroradiology 2004;46:72-4.

  79. Iannucci G, Rovaris M, Giacomotti, Comi G, Filippi M. Correlation of multiple sclerosis measures derived from T2 weighted, T1 weighted magnetization transfer and diffusion tensor MR imaging. AJNR 2001: 22: 1462-7.

  80. Jellison BJ, Field AS, Medow J, Lazar M, Salamat S, Alexander AL. Diffusion tensor imaging of cerebral white matter: a pictoral review of physics fiber tract anatomy and tumor imaging patterns. AJNR 2004; 25: 356-69.

  81. Venkatesh SK, Gupta RK. Pyogenic infections. In: Gupta RK, Lufkin RB, eds. MR imaging and spectroscopy of central nervous system infection. New York. Kluwer/Plenum 2001:57-93.

  82. Gupta RK, Hasan KM, Mishra AM, Jha D, HusainM, Prasad KN, Narayana PA. High fractional anisotropy in brain abscesses versus other cystic intracranial lesions. AJNR 2005;26:1107-11.

  83. Firemark HM. Spinal cysticercosis. Arch Neurol 1978;83:250-1

  84. Schweller OG, Sperlescu A, Balbo RJ, Rossitti SL. Compressao mieloradicular por cisticercose. Rev Bras Reumatol 1988;28:203-5.

  85. Barrinagarrementeria F, Del Brutto OH. Lacunar syndrome due to neurocysticercosis. Arch Neurol 1989;46:415-7.

  86. Soto-Hernández JL, Gómez-Llata S, Rojas-Echevarri LA, Texeira F, Romero V. Subarachnoidal hemorrhage secondary to a ruptured inflammatory aneurysm: a possible manifestation of neurocysticercosis: Case report. Neurosurgery 1996;38:197-200.

  87. Kumar S, Rajshekher G, Prabhakar S. Positron emission tomography in neurological diseases. Neurol India 2005;53:149-55.

  88. Masdeu JC, Arbizu J, Toledo J, Valero M. SPECT and PET in neurology. Neurología 2006;21:219-25.

  89. Reuter S, Schirrmeister H, Kratzer W, Dreweck C, Reske SN, Kern P. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Clin Infect Dis 1999;29:1157-63.

  90. Reuter S, Buck A, Grebe O, Nussle-Kugele K, Kern P, et al. Salvage treatment with amphotericin B in progressive human alveolar echinococcosis. Antimicrob Agents Chemother 2003;47:3586-91.

  91. Reuter S, Buck A, Manfras B, Kratzer W, Seitz HM, Darge K, et al. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology 2004;39:509-17.

  92. Nagayama M, Shinohara Y, Nagakura K, Izumi Y, Takagi S. Distinctive serial magnetic resonante changes in a young woman with rapidly evolved neurocysticercosis with positron emision tomography results. J Neuroimaging 1996;6:198-201.




2020     |     www.medigraphic.com